Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Clinical trial NCT06144606 · RECRUITING
Trial details
- NCT number
- NCT06144606
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-26
- Primary completion
- 2028-11-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.